Return to Listing

1 result(s) for

PI Name Protocol # Title
Sarah Nagle STUDY00016830 [NCI CIRB] A Randomized Double-Blind Phase III Study of Ibrutinib During and Following Autologous Stem Cell Transplantation Versus Placebo in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma of the Activated B-Cell Subtype
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080